Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Pancreatitis I: Introduction01:24

Chronic Pancreatitis I: Introduction

818
The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
818
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

447
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
447
Pancreas01:19

Pancreas

2.8K
The pancreas, an essential organ in the human body, is a pinkish-gray elongated structure located posterior to the stomach. It extends laterally from the duodenum towards the spleen and is firmly bound to the posterior wall of the abdominal cavity. The organ's surface has a lumpy, lobular texture that gives it a unique appearance.
The broad head of the pancreas lies within the loop formed by the duodenum, while its slender body reaches towards the spleen. The tail of the pancreas is short...
2.8K
Acute Pancreatitis II: Clinical Manifestations and Management01:30

Acute Pancreatitis II: Clinical Manifestations and Management

980
Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
980
Acute Pancreatitis I: Introduction01:27

Acute Pancreatitis I: Introduction

1.4K
Pancreatitis is inflammation of the pancreas, an organ located behind the stomach. It can be either acute or chronic.
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include:
1.4K
Cells and Secretions of the Pancreas01:16

Cells and Secretions of the Pancreas

6.3K
The pancreas, a vital organ within the abdominal cavity, plays dual roles in the digestive and endocrine systems, collaborating with exocrine and endocrine cells to maintain optimal digestion and blood sugar levels.
Exocrine function is carried out by acinar cells, organized into clusters known as acini. These cells contribute to digestion by releasing substantial quantities of enzyme-rich, alkaline digestive juices.
Concurrently, the dispersed clusters of endocrine cells throughout the...
6.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

When Is a Test "Genetic?" The Case of Multi-Cancer Early Detection Tests.

Journal of insurance medicine (New York, N.Y.)·2026
Same authorSame journal

Biological Clocks: Ready for Prime Time?

Journal of insurance medicine (New York, N.Y.)·2026
Same author

AI in Healthcare: How Relevant to Medical Risk Selection?

Journal of insurance medicine (New York, N.Y.)·2026
Same author

When Is a Test Genetic? The Case of Multi-Cancer Early Detection Tests.

Journal of insurance medicine (New York, N.Y.)·2026
Same author

Long Covid in Year 5: Some Progress, Still Many Questions.

Journal of insurance medicine (New York, N.Y.)·2025
Same author

Critical Illness Insurance: In Search of Its Identity.

Journal of insurance medicine (New York, N.Y.)·2025
Same journal

Creating Evidence-Based Ratings and Life Expectancies Medical Impairments.

Journal of insurance medicine (New York, N.Y.)·2026
Same journal

The Smoking Dilemma: A Technical Deep Dive.

Journal of insurance medicine (New York, N.Y.)·2026
Same journal

GLP-1 Therapies and Mortality Risk: Implications for Life Insurers.

Journal of insurance medicine (New York, N.Y.)·2026
Same journal

Identifying Benzodiazepine Abuse: A Report of 3 Cases.

Journal of insurance medicine (New York, N.Y.)·2026
Same journal

Between Fear and Adoption: The AI Paradox in Medico-Legal Practice Among National Insurance Physicians.

Journal of insurance medicine (New York, N.Y.)·2026
See all related articles

Related Experiment Video

Updated: Mar 5, 2026

Treatment of Middle-segment Pancreatic Benign Tumor Using Laparoscopic Central Pancreatectomy with End-to-end Pancreatic Duct Reconstruction
05:11

Treatment of Middle-segment Pancreatic Benign Tumor Using Laparoscopic Central Pancreatectomy with End-to-end Pancreatic Duct Reconstruction

Published on: January 2, 2026

110

Pancreatic Cysts.

Timothy Meagher1, Andreas Armuss1

  • 1Meagher: Vice-President and Medical Director, Munich Re, Montreal; Associate Professor of Medicine, McGill University, Montréal, Québec; Armuss: Medical Officer, Munich Re, Munich, Germany.

Journal of Insurance Medicine (New York, N.Y.)
|March 23, 2017
PubMed
Summary
This summary is machine-generated.

Pancreatic cystic neoplasms (PCNs) are increasingly found due to imaging. Identifying malignant PCNs is crucial as they can transform, guiding optimal management strategies.

Keywords:
Pancreaslife insurancemortality.pancreatic cysts

More Related Videos

Author Spotlight: Advancements in Retroperitoneal Approach for Necrotizing Pancreatitis
03:42

Author Spotlight: Advancements in Retroperitoneal Approach for Necrotizing Pancreatitis

Published on: March 15, 2024

1.3K
Laparoscopic Choledochal Cyst Excision and Roux-en-Y Choledochojejunostomy in Adults
04:14

Laparoscopic Choledochal Cyst Excision and Roux-en-Y Choledochojejunostomy in Adults

Published on: February 28, 2025

947

Related Experiment Videos

Last Updated: Mar 5, 2026

Treatment of Middle-segment Pancreatic Benign Tumor Using Laparoscopic Central Pancreatectomy with End-to-end Pancreatic Duct Reconstruction
05:11

Treatment of Middle-segment Pancreatic Benign Tumor Using Laparoscopic Central Pancreatectomy with End-to-end Pancreatic Duct Reconstruction

Published on: January 2, 2026

110
Author Spotlight: Advancements in Retroperitoneal Approach for Necrotizing Pancreatitis
03:42

Author Spotlight: Advancements in Retroperitoneal Approach for Necrotizing Pancreatitis

Published on: March 15, 2024

1.3K
Laparoscopic Choledochal Cyst Excision and Roux-en-Y Choledochojejunostomy in Adults
04:14

Laparoscopic Choledochal Cyst Excision and Roux-en-Y Choledochojejunostomy in Adults

Published on: February 28, 2025

947

Area of Science:

  • Gastroenterology and Hepatology
  • Surgical Oncology
  • Diagnostic Imaging

Background:

  • Pancreatic cysts are increasingly detected via widespread abdominal imaging.
  • Pancreatic cystic neoplasms (PCNs) represent over half of all pancreatic cysts.
  • PCNs carry the potential for malignant transformation, unlike other cyst types.

Purpose of the Study:

  • To provide guidance in identifying malignant pancreatic cystic neoplasms.
  • To summarize current debates on the optimal management of PCNs.
  • To aid clinicians in risk stratification for pancreatic cysts.

Main Methods:

  • Literature review of diagnostic criteria for PCNs.
  • Analysis of current management guidelines and controversies.
  • Synthesis of data regarding malignant potential and progression.

Main Results:

  • The majority of PCNs are benign at diagnosis and follow a benign course.
  • Distinguishing between benign and malignant PCNs is a key clinical challenge.
  • Risk stratification requires careful evaluation of cyst characteristics.

Conclusions:

  • Accurate identification of malignant PCNs is essential for patient outcomes.
  • Optimal management strategies for PCNs remain a subject of ongoing discussion.
  • Further research is needed to refine diagnostic and therapeutic approaches for PCNs.